Results 31 to 40 of about 11,423 (215)

Pharmacological correction of retinal ischemia/reperfusion by minoxidil [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2018
Introduction/Objective. The objective of this paper was to increase the effectiveness of pharmacological correction of retinal ischemia-reperfusion by using minoxidil. Methods. The research was carried out on 180 Wistar rats.
Peresypkina Anna A., Gubareva Victoria O., Levkova Elena A., Shabelnikova Anna S., Pokrovskii Mikhail V.   +4 more
doaj   +1 more source

Summation and Recommendations for the Safe and Effective Use of Topical and Oral Minoxidil.

Journal of American Academy of Dermatology
BACKGROUND Topical minoxidil, approved for the treatment of androgenetic alopecia, also has efficacy in many other hair loss disorders, its use limited due to the need for at least daily application.
Elise A Olsen, R. Sinclair, Maria K. Hordinsky, N. Mesinkovska, N. Sadick, Jerry Shapiro, Wilma F. Bergfeld   +6 more
semanticscholar   +1 more source

Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia.

International Journal of Biological Macromolecules, 2023
Androgenetic alopecia (AGA) is a transracial and cross-gender disease worldwide with a higher prevalence among young individuals. Traditional oral or subcutaneous injections are often used to treat AGA, however, they may cause severe side-effects and ...
Peixin Li, Yanfang Sun, L. Nie, A. Shavandi, K. Yunusov, Yinjian Hua, Guohua Jiang   +6 more
semanticscholar   +1 more source

Short-Term Topical Minoxidil Use Associated with Acute Central Serous Chorioretinopathy: A Case Report

Case Reports in Ophthalmology
Introduction: Minoxidil is a topical, over-the-counter, FDA-approved drug used to treat male and female pattern hair loss. Three case reports were published associating long-term use of topical minoxidil to central serous chorioretinopathy ...
Jacob Brucker, Brian Mihok, Jeffrey Bloom   +2 more
doaj   +1 more source

Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride

Indian Dermatology Online Journal, 2015
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar, T Nandhini, Vani Vasanth, Rashmi Sriram, Shreya Navale   +4 more
doaj   +1 more source

Infantile generalized hypertrichosis caused by topical minoxidil [PDF]

Anais Brasileiros de Dermatologia, 2016
Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon, Caroline Henkin, Paulo Ricardo Martins de Souza, Hiram Larangeira de Almeida Jr   +3 more
doaj   +1 more source

Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence.

Toxicology and Applied Pharmacology, 2023
Finasteride and minoxidil are medicaments commonly prescribed for treating benign prostatic hyperplasia (BPA), hypertension, and/or androgenetic alopecia (AGA).
F. Santana, A. Lozi, R. V. Gonçalves, Janaina da Silva, S. L. P. da Matta   +4 more
semanticscholar   +1 more source

Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis

Journal of Dermatological Treatment
Objective This systematic review evaluates the efficacy of minoxidil alone versus minoxidil with low-level laser therapy (LLLT) for androgenic alopecia.Study design systematic review and meta-analysis.Methods An online search of PubMed, Web of Science ...
Abdulmajeed Alosaimi, Abdullah Algarni, Abdulrahman Alharbi, Abdulmalik Alotaibi, Abdullah Alomairi, Mohannad Alsurayhi, Waleed Alharbi   +6 more
doaj   +1 more source

Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.

JAMA dermatology
Importance The results of small studies suggest that off-label use of low-dose oral minoxidil (LDOM) may be safe and effective for patients with hair loss, but larger trials and standardized guidelines are lacking.
Y. Akiska, P. Mirmirani, Ingrid Roseborough, Erin Mathes, T. Bhutani, A. Ambrosy, C. Aguh, Wilma F. Bergfeld, V. Callender, L. Castelo-Soccio, G. Cotsarelis, Brittany Craiglow, Nisha Desai, I. Doche, Bruna Duque-Estrada, D. Elston, Carolyn Goh, L. Goldberg, R. Grimalt, Ali Jabbari, Victoria Jolliffe, B. King, Charlotte LaSenna, Yolanda M. Lenzy, J. Lester, N. Lortkipanidze, K. L. Lo Sicco, A. McMichael, Nekma Meah, N. Mesinkovska, M. Miteva, A. Mostaghimi, Y. Ovcharenko, Melissa Piliang, B. Piraccini, A. Rakowska, K. Salkey, A. Schmidt, Jerry Shapiro, C. Sibbald, R. Sinclair, Poonkiat Suchonwanit, Susan Taylor, A. Tosti, S. Vañó‐Galván, D. Wall, Jennifer M. Fu   +46 more
semanticscholar   +1 more source

Evaluation of platelet‐rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial

Journal of Cosmetic Dermatology, 2023
Platelet‐rich plasma plus basic fibroblast growth factor (PRPF) has been confirmed to be a safe and valuable therapy for androgenetic alopecia (AGA). However, the efficacy of PRPF combined with minoxidil treatment remains unknown.
Shulian Wu, Shizhao Liu, Jian Chen, Da-mao Dai, Weijie Liu, Demengjie Le, Qing Guan, Y. Miao, Zhi-qi Hu, Qian Qu   +9 more
semanticscholar   +1 more source